Global Botulinum Toxin Market: Size, Trends and Forecasts (2017-2021)

  • ID: 4454536
  • Report
  • Region: Global
  • 68 Pages
  • Daedal Research
UP TO OFF
until Dec 31st 2018
1 of 4

The report titled “Global Botulinum Toxin Market: Size, Trends and Forecasts (2017-2021)” provides an in-depth analysis of the global botulinum toxin market with detailed analysis of the actual and the expected market size along with the market size of each market segment on the basis of application, products as well as regional.

The report provides detailed regional analysis of the US, Europe, Japan, Asia (excluding Japan) and Korea for the botulinum toxin market. Regional analysis includes market share of each region or country and the actual and forecasted market size of the botulinum toxin market along with the market segments of the aforementioned regions.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global botulinum toxin market has also been forecasted for the period 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global botulinum toxin market is stiff and dominated by the big players like Allergan. Further, key players of the botulinum toxin market Ipsen and Revance are also profiled with their financial information and respective business strategies.

Country Coverage

  • The US
  • Europe
  • Japan
  • Asia (excluding Japan)
  • Korea

Company Coverage

  • Allergan Plc.
  • Ipsen
  • Revance Therapeutics, Inc.

Executive Summary

Botulinum toxin is provided by a kind of bacteria called as clostridium botulinum, a gram-positive anaerobic bacterium. Botulinum toxin is fragmented into seven separate neurotoxins and used in therapeutic and aesthetic procedures. It is utilized as a part of relatively every sub-forte of pharmaceutical and for restorative reason for briefly lessening glabellar temple glare lines. The different botulinum toxins have singular potencies, and care is required to guarantee appropriate apply and avoid medication errors.

The global botulinum toxin market has increased at a significant annual growth rate in 2016 as compared to the preceding year 2015 and projections are made that the market would rise in the next five years i.e. 2017-2021 tremendously.

The upsurge in the market was due to various factors such as increased patient comfort, shorter procedure times and immediate results. The market can be segmented on the basis of application as therapeutics and cosmetic/aesthetic, of which therapeutics govern the market.

The major growth drivers for the botulinum toxin market are: ageing population, escalating numbers of surgeons, upsurge in facial aesthetics procedures, rising alternative of non-surgical procedures, increasing healthcare spending in emerging markets. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as potential health risk associated with botulinum toxin and botulinum toxins as bio-terror threat.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

1. Executive Summary

2. Introduction
2.1 Botulinum Toxin: An Overview
2.2 Botulinum Toxin: Indications Overview
2.3 Botulinum Toxin: Products Overview

3. Global Market Analysis
3.1 Global Botulinum Toxin Market: An Analysis
3.1.1 Global Botulinum Toxin Market by Value
3.1.2 Global Botulinum Toxin Market by Application
3.1.3 Global Botulinum Toxin Market by Products
3.1.4 Global Botulinum Toxin Market by Region
3.2 Global Botulinum Toxin Market: Application Analysis
3.2.1 Global Therapeutic Botulinum Toxin Market by Value
3.2.2 Global Therapeutic Botulinum Toxin Market by Indication
3.2.3 Global Cosmetic/Aesthetic Botulinum Toxin Market by Value
3.2.4 Global Cosmetic/Aesthetic Botulinum Toxin Market by Number of Procedures
3.3 Global Botulinum Toxin Market: Product Analysis
3.3.1 Global Botox Market by Value
3.3.2 Global Dysport Market by Value
3.3.3 Global Xeomin Market by Value

4. Regional Market Analysis
4.1 The US Botulinum Toxin Market: An Analysis
4.1.1 The US Botulinum Toxin Market by Value
4.1.2 The US Botulinum Toxin Market by Application
4.2 Europe Botulinum Toxin Market: An Analysis
4.1.1 Europe Botulinum Toxin Market by Value
4.2.2 Europe Botulinum Toxin Market by Application
4.3 Japan Botulinum Toxin Market: An Analysis
4.3.1 Japan Botulinum Toxin Market by Value
4.3.2 Japan Botulinum Toxin Market by Application
4.4 Asia (Excluding Japan) Botulinum Toxin Market: An Analysis
4.4.1 Asia (Excluding Japan) Botulinum Toxin Market by Value
4.4.2 Korea Botulinum Toxin Market by Value

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Ageing Population
5.1.2 Escalating Number of Plastic Surgeons
5.1.3 Upsurge in Facial Aesthetics Procedures
5.1.4 Rising Alternative of Non-Surgical Procedures
5.1.5 Increasing Healthcare Spending in Emerging Markets
5.2 Challenges
5.2.1 Potential Health Risk Associated with Botulinum Toxin
5.2.2 Botulinum Toxins As  Bio-terror Threat
5.3 Market Trends
5.3.1 Rise In Medical Tourism
5.3.2 Reduced Safety Concerns and Simple & Instant Characteristic

6. Competitive Landscape
6.1 Global Botulinum Toxin Market by Players
6.1.1 Global Botulinum Toxin  Market Share by Players
6.1.2 Global Botulinum Toxin  Market Players by Sales
6.1.3 Global Botulinum Toxin  Market Key Development Schedule for Players
6.1.4 Global Botulinum Toxin  Market Key Development for Players
6.2 Korea Botulinum Toxin  Market  by Players
6.2.1 Korea Botulinum Toxin  Market Share by Players
6.2.2 Korea Botulinum Toxin  Market Players by Sales

7. Company Profiles
7.1 Allergan Plc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Ipsen
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Revance Therapeutics, Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy

List of Figures
Figure 1: Types of Botulinum Toxin
Figure 2: Botulinum Toxin Products
Figure 3: Global Botulinum Toxin Market by Value; 2014-2016 (US$ Billion)
Figure 4: Global Botulinum Toxin Market by Value; 2017-2021 (US$ Billion)
Figure 5: Global Botulinum Toxin Market by Application; 2016
Figure 6: Global Botulinum Toxin Market by Products;2016
Figure 7: Global Botulinum Toxin Market by Region;2016
Figure 8: Global Therapeutic Botulinum Toxin Market by Value; 2016-2021 (US$ Billion)
Figure 9: Global Therapeutic Botulinum Toxin Market by Indication; 2016
Figure 10: Global Cosmetic/Aesthetic Botulinum Toxin Market by Value; 2016-2021 (US$ Billion)
Figure 11: Global Cosmetic/Aesthetic Botulinum Toxin Market Number of Procedures by Countries; 2016
Figure 12: Global Botox Market by Value; 2016-2021 (US$ Billion)
Figure 13: Global Dysport Market by Value; 2016-2021 (US$ Billion)
Figure 14: Global Xeomin Market by Value; 2016-2021 (US$ Billion)
Figure 15: The US Botulinum Toxin Market by Value; 2014-2016 (US$ Billion)
Figure 16: The US Botulinum Toxin Market by Value; 2017-2021 (US$ Billion)
Figure 17: The US Botulinum Toxin Market by Application; 2014-2021 (US$ Billion)
Figure 18: Europe Botulinum Toxin Market by Value; 2014-2016 (US$ Billion)
Figure 19: Europe Botulinum Toxin Market by Value; 2017-2021 (US$ Billion)
Figure 20: Europe Botulinum Toxin Market by Application; 2014-2021 (US$ Billion)
Figure 21: Japan Botulinum Toxin Market by Value; 2014-2016 (US$ Million)
Figure 22: Japan Botulinum Toxin Market by Value; 2017-2021 (US$ Million)
Figure 23: Japan Botulinum Toxin Market by Application; 2014-2021 (US$ Million)
Figure 24: Asia (Excluding Japan) Botulinum Toxin Market by Value; 2014-2016 (US$ Million)
Figure 25: Asia (Excluding Japan) Botulinum Toxin Market by Value; 2017-2021 (US$ Million)
Figure 26: Korea Botulinum Toxin Market by Value; 2014-2016 (US$ Million)
Figure 27: Korea Botulinum Toxin Market by Value; 2017-2021 (US$ Million)
Figure 28: Global Population by Age Groups; 2015-2030 (Million)
Figure 29: Number of Plastic Surgeons Per 100,000 Citizens by Nation; 2010-2015
Figure 30: Global Number of Facial Aesthetic Procedures; 2010-2015 (Percentage, %)
Figure 31: Global Healthcare Expenditure; 1995-2022 (US$ Trillion)
Figure 32: Global Botulinum Toxin Market Share by Players; 2016 (Percentage,%)
Figure 33: Global Botulinum Toxin Market Players by Sales; 2012-2016 (US$ Million)
Figure 34: Korea Botulinum Toxin Market Share by Players ; 2016 (Percentage,%)
Figure 35: Korea Botulinum Toxin Market Players by Sales; 2012-2016 (US$ Million)
Figure 36: Allergan Plc. Revenue; 2012-2016 (US$ Billion)
Figure 37: Allergan Plc. Revenue by Segments; 2016
Figure 38: Ipsen Net Sales; 2012-2016 (US$ Billion)
Figure 39: Ipsen Net Sales by Segments; 2016
Figure 40: Ipsen Net Sales by Regions; 2016
Figure 41: Revance Therapeutics, Inc. Revenue; 2012-2016 (US$ Thousand)
Figure 42: Revance Therapeutics, Inc. Research and Development Expenditure; 2012-2016 (US$ Million)

List of Tables
Table 1: Applicable Indications of Botulinum Toxin
Table 2: Major Non-surgical Facial Aesthetic Procedures
Table 3: Global Botulinum Toxin Market Key Development Schedule for Players
Table 4: Global Botulinum Toxin Market Key Products; 2016

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergan Plc.
  • Ipsen
  • Revance Therapeutics, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll